|
|
|
Volumn 92, Issue 1, 2003, Pages 39-46
|
|
Monoclonal antibody therapy of non-Hodgkin's lymphoma: the Rituximab story.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CD20 ANTIGEN;
IBRITUMOMAB TIUXETAN;
MONOCLONAL ANTIBODY;
RITUXIMAB;
DRUG COMBINATION;
DRUG DELIVERY SYSTEM;
DRUG SCREENING;
HUMAN;
IMMUNOLOGY;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
NONHODGKIN LYMPHOMA;
RADIOIMMUNOTHERAPY;
REVIEW;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
DRUG DELIVERY SYSTEMS;
DRUG EVALUATION;
DRUG THERAPY, COMBINATION;
HUMANS;
LYMPHOMA, NON-HODGKIN;
RADIOIMMUNOTHERAPY;
TREATMENT OUTCOME;
|
|
EID: 0038348947
PISSN: 00257028
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (63)
|
